VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
VBI Vaccines reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
VBI Vaccines reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at VBI Vaccines received on average a compensation package of $1.1M, a 69% increase compared to previous year.
Average pay of disclosed executives at VBI Vaccines
Jeffrey R. Baxter, Chief Executive Officer, received $1.5M in total, which increased by 81% compared to 2017. 42% of Baxter's compensation, or $629K, was in option awards. Baxter also received $255K in bonus, $465K in salary, $84K in stock awards, as well as $61K in other compensation.
Francisco Diaz-Mitoma, Chief Medical Officer, received a compensation package of $957K, which increased by 47% compared to previous year. 45% of the compensation package, or $426K, was in option awards.
David E. Anderson, Chief Scientific Officer, earned $922K in 2018, a 77% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2019.